Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenofovir for chronic hepatitis B not responding to lamivudine and adefovir
ACTRN12606000381583Phase 2Recruiting
- Sponsor
- Austin Health
- Start
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of tenofovir disoproxil fumarate in Chronic Hepatitis B (CHB), sponsored by Austin Health. Started Sep 2006; status: recruiting.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ACTRN12606000381583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12606000381583.